TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
PharMedCon Europe AB
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
800
|
2,037
|
0 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
454
|
1,600
|
-25 |
| EBITDA |
431
|
1,587
|
-25 |
| Total assets |
3,534
|
3,211
|
1,750 |
| Current assets |
832
|
1,112
|
26 |
| Current liabilities |
62
|
120
|
11 |
| Equity capital |
3,326
|
2,971
|
1,707 |
| - share capital |
50
|
50
|
50 |
| Employees (average) |
1
|
1
|
0 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
94.1%
|
92.5%
|
97.5% |
| Turnover per employee |
800
|
2,037 | |
| Profit as a percentage of turnover |
56.8%
|
78.5% | |
| Return on assets (ROA) |
12.8%
|
49.8%
|
-1.4% |
| Current ratio |
1341.9%
|
926.7%
|
236.4% |
| Return on equity (ROE) |
13.7%
|
53.9%
|
-1.5% |
| Change turnover |
-1,237
|
2,037
|
0 |
| Change turnover % | -61% | ||
| Chg. No. of employees |
0
|
1
|
0 |
| Chg. No. of employees % | 0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.